Literature DB >> 2042979

Non-Hodgkin's lymphoma in rheumatoid arthritis.

D Porter, R Madhok, H Capell.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2042979      PMCID： PMC1004408          DOI： 10.1136/ard.50.5.275

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  J Karsh; G Dorval; C K Osterland
Journal:  Clin Immunol Immunopathol       Date:  1981-06

2.  Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice.

Authors:  K Kärre; G O Klein; R Kiessling; G Klein; J C Roder
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

3.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

4.  Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R B Lewis; C W Castor; R E Knisley; G G Bole
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

5.  Long-term effects of azathioprine in rheumatoid arthritis.

Authors:  M B Urowitz; H A Smythe; T Able; C S Norman; C Travis
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

6.  Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  J H Dobloug; O Førre; T K Kvien; T Egeland; M Degré
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

7.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

Authors:  L J Kinlen; A G Sheil; J Peto; R Doll
Journal:  Br Med J       Date:  1979-12-08

8.  Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.

Authors:  J M Depper; H G Bluestein; N J Zvaifler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.

Authors:  A J Silman; J Petrie; B Hazleman; S J Evans
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

Review 10.  Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.

Authors:  D T Purtilo
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242
View more
  6 in total

1.  Heredofamilial deficiency of monocyte esterase in patients with rheumatoid arthritis.

Authors:  A L Bell; G M Markey; M D McCaigue; D Middleton; J A McCormick; A G Wilson; T C Morris
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents.

Authors:  Y Levy; J George; A Abraham; A Afek; A Livneh; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

3.  Chromosomal changes in rheumatoid arthritis patients treated with CPH82.

Authors:  S Rantapää Dahlqvist; I Nordenson
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

4.  Clinical and histological coexistence of inflammatory pseudotumour of the lymph nodes and rheumatoid arthritis.

Authors:  Paolo Manganelli; Pieranna Fietta; Eugenia Marta Martella; Federico Quaini
Journal:  Clin Rheumatol       Date:  2003-09-30       Impact factor: 2.980

5.  Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis.

Authors:  W G McCluggage; H Bharucha
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

Review 6.  Paraneoplastic rheumatic syndromes.

Authors:  H J Mitnick
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.686
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.